Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: 23 - You Need To See This

Zscaler (NASDAQ:ZS) reported stronger-than-expected fiscal third-quarter results, with management highlighting growth in annual recurring revenue, record operating margin and rising demand for its zero-trust security platform as enterprises adopt artificial intelligence tools. Chairman and CEO Jay

MarketBeat

Stocks Finish Mostly Higher on Iran Peace Progress

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.61%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.76%. June E-mini S&P futures (ESM26 ) rose +0.61%, and June E-mini Nasdaq futures...

Barchart

How major US stock indexes fared Tuesday 5/26/2026

The U.S. stock market rose to more all-time highs and caught up with climbs for others around the world from the day before, when President Donald Trump said negotiations were "proceeding nicely" with Iran on ending their war

AAP

From analysis to the latest developments in health,
read the most diverse news in one place.

Another surge for Micron, Wall Street's latest $1 trillion company, sends US stocks to records

The U.S. stock market rose to records as it caught up with climbs for others around the world from the day before, when President Donald Trump said negotiations were "proceeding nicely" with Iran on ending their war

AAP

US stocks today: S&P 500 hits record closing high on AI optimism, Micron joins $1 trillion club

US stocks closed mixed with Nasdaq and S&P 500 hitting record levels as AI-driven optimism lifted tech and chip stocks. Micron surged into the $1 trillion club after a strong price target hike. Geopolitical tension from US-Iran strikes pushed oil higher, while investors stayed focused on AI earnings momentum.

The Economic Times

Wall Street rises to more records as US stocks catch up to the world's gains from the day before

AAP

EyePoint Pharmaceuticals Eyes Transformative 2026 as DURAVYU Phase 3 Data Nears

Eyepoint Pharmaceuticals (NASDAQ:EYPT) executives said the company remains on track to report top-line data from its Phase 3 wet age-related macular degeneration program for DURAVYU, also known as EYP-1901, beginning in August, with a second pivotal trial expected to follow about two months later.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

5 High-Yield Stocks and ETFs to Buy and Hold for the Next Decade

Five high-yield names spanning pharmaceuticals, consumer staples, energy, and ETFs offer income investors compelling yields and durable businesses for a ten-year hold.

MarketBeat

S&P 500 and Nasdaq 100 Climb to Record Highs on Tech Stock Strength

The S&P 500 Index ($SPX ) (SPY ) today is up +0.81%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.74%. June E-mini S&P futures (ESM26 ) are up +0.77%, and June E-mini Nasdaq futures...

Barchart

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks.

AAP

After NVIDIA, Broadcom's Earnings Are Next—Here's What to Watch

Broadcom's next earnings report is on the horizon. While the financials will be key, see why Broadcom's thoughts on Alphabet could be a needle mover.

MarketBeat

Stocks Jump on US-Iran Peace Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.72%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.42%. June E-mini S&P futures (ESM26 ) are up +0.62%, and June E-mini Nasdaq futures...

Barchart

VNET Group Q1 Earnings Call Highlights

VNET Group (NASDAQ:VNET) said its first-quarter 2026 results were driven by rapid expansion in its wholesale internet data center business, as management pointed to rising artificial intelligence-related demand and new large-scale orders as key growth catalysts. Rotating President Sharon Liu said t

MarketBeat

Freightos Q1 Earnings Call Highlights

Freightos (NASDAQ:CRGO) reported a softer-than-expected first quarter as disruptions in Middle East trade corridors weighed on transaction activity, even as the company said it continued to expand its carrier network and build its solutions pipeline. Chief Executive Pablo Pinillos, who stepped into

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

US stocks today: US stocks rise near record highs on Iran deal hopes, oil climbs

U.S. stocks rose Tuesday, catching up after a holiday, as optimism over U.S.-Iran talks lifted sentiment. The S&P 500, Nasdaq and Dow hovered near record highs, while oil prices climbed amid geopolitical tensions. Asian and European markets were mixed as investors weighed conflict risks against hopes of a diplomatic breakthrough.

MarketBeat

5 Stocks Winning the AI Race While Everyone Watches NVIDIA

The real AI growth story has shifted to physical infrastructure. Keith Kaplan of TradeSmith identifies 5 stocks across memory, photonics, cooling, power, and the grid that still have significant upside.

AAP

US stocks rise and catch up with gains in overseas markets

The U.S. stock market is rising as it catches up with others around the world that climbed the day before, when President Donald Trump said negotiations were "proceeding nicely" with Iran on ending their war

MarketBeat

KLA Flags Stronger Chip Equipment Demand, Rare 2027 Visibility at JPMorgan Conference

KLA (NASDAQ:KLAC) is seeing stronger momentum across semiconductor equipment markets than it expected earlier in the year, with demand improving across leading-edge logic, memory and advanced packaging, Chief Financial Officer Bren Higgins said at J.P. Morgan’s 54th annual Global Technology, Media a

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

Nasdaq gets SEC nod to list Bitcoin index options. Here’s why it matters

The SEC has greenlit Nasdaq's Bitcoin index options, a significant move integrating Wall Street with digital assets. These cash-settled, European-style contracts offer US equity traders a new avenue for Bitcoin exposure, distinct from spot ETF options. While approved by the SEC, final clearance from the CFTC is pending before trading…

MarketBeat

J.B. Hunt Highlights Intermodal Share Gains, Pricing Upside at Wolfe Conference

J.B. Hunt Transport Services (NASDAQ:JBHT) executives said intermodal demand remains “pretty good,” with volume gains driven more by company-specific share wins than by a broadly robust freight market, during a Wolfe Research conference session moderated by Scott Group, managing director and senior

MarketBeat

JOYY Q1 Earnings Call Highlights

JOYY (NASDAQ:YY) reported its strongest year-over-year revenue growth in recent years in the first quarter of 2026, as its social entertainment business returned to growth and newer businesses in advertising technology and commerce continued to scale. The company said total net revenue rose 12.4% y

MarketBeat

Intel CEO Touts Balance Sheet Progress, Foundry Gains and AI CPU Demand

Intel (NASDAQ:INTC) Chief Executive Officer Lip-Bu Tan said the company has made progress on strengthening its balance sheet, improving execution and rebuilding customer trust, while acknowledging that its foundry ambitions remain a long-term effort. Speaking with J.P. Morgan semiconductor analyst

MarketBeat

Intapp Says AI Is Driving Demand as Celeste Tackles Compliance Risks

Intapp (NASDAQ:INTA) executives said artificial intelligence is emerging as a demand driver for the company’s professional-services software platform, particularly as large law firms, accounting firms, consulting firms, investment banks and private capital firms look for compliant ways to automate w

MarketBeat

Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances

Inovio Pharmaceuticals (NASDAQ:INO) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of eight directors and the ratification of Ernst & Young LLP as the company’s independent registered public accounting firm for the year ending Dec. 31,

MarketBeat

Incyte Sets Mid-Year Phase 3 Trial for CALR Antibody 989 as Pipeline Updates Roll Out

Incyte (NASDAQ:INCY) Chief Medical Officer Steven Stein outlined the company’s development priorities across hematology, oncology and immunology, with a particular focus on its mutant CALR antibody 989, during a company news event. Stein said myeloproliferative neoplasms remain “front and center” f

1 … 22 23 24 25

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.